Company Overview of MetronomX, Pte. Ltd.
MetronomX, Pte. Ltd. develops cancer chemotherapeutic metronomic therapies. It develops MNX-100 for relapsing and/or refractory neuroblastoma and medulloblastoma; and MNX-200, a metronomic formulation of an approved and used IV cancer chemotherapeutic drug. The company was founded in 2010 and is based in Houston, Texas.
5138 Cheena Drive
Houston, TX 77096
Founded in 2010
Key Executives for MetronomX, Pte. Ltd.
Similar Private Companies By Industry
|PEGUS Research, Inc.||United States|
|Access Product Marketing, LLC||United States|
|Collabra Pharma, Inc.||United States|
|Amalyte Pharmaceuticals, LLC||United States|
|HPL Biomedical, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Deerfield, IL | Takeda Pharmaceuticals North AmericaPosted: Apr 15
- New York, NY | PwCPosted: Aug 20
- Florham Park, NJ | PwCPosted: Aug 20
- Newark, NJ | InventivPosted: Apr 17
Sponsored Financial Commentaries
To contact MetronomX, Pte. Ltd., please visit www.metronomxgroup.com. Company data is provided by Capital IQ. Please use this form to report any data issues.